Cancer Health editor-in-chief Liz Highleyman interviews Massimo Colombo, MD, of Humanitas Hospital and the University of Milan in Italy and the EASL International Liver Foundation about the changing epidemiology of liver cancer and the promise of new targeted therapies and immunotherapies for this difficult-to-treat cancer.

This video from the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) is courtesy of IFARA, a non-profit group that produces video updates from HIV conferences. See all IFARA’s CROI 2018 videos here.